Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 33 studies | 47% ± 17% | |
pericyte | 19 studies | 37% ± 19% | |
basal cell | 17 studies | 42% ± 20% | |
epithelial cell | 17 studies | 42% ± 20% | |
ciliated cell | 14 studies | 39% ± 13% | |
connective tissue cell | 14 studies | 43% ± 18% | |
smooth muscle cell | 14 studies | 31% ± 16% | |
macrophage | 13 studies | 31% ± 17% | |
myofibroblast cell | 12 studies | 33% ± 20% | |
secretory cell | 10 studies | 39% ± 14% | |
mesothelial cell | 10 studies | 47% ± 17% | |
type I pneumocyte | 9 studies | 53% ± 16% | |
type II pneumocyte | 8 studies | 41% ± 17% | |
goblet cell | 8 studies | 39% ± 14% | |
club cell | 7 studies | 52% ± 18% | |
abnormal cell | 7 studies | 37% ± 22% | |
alveolar macrophage | 6 studies | 43% ± 13% | |
ionocyte | 6 studies | 40% ± 10% | |
respiratory goblet cell | 6 studies | 43% ± 23% | |
oligodendrocyte | 6 studies | 25% ± 7% | |
enterocyte | 6 studies | 53% ± 14% | |
astrocyte | 5 studies | 27% ± 17% | |
transit amplifying cell | 5 studies | 39% ± 21% | |
brush cell | 5 studies | 28% ± 5% | |
neuroendocrine cell | 5 studies | 67% ± 25% | |
progenitor cell | 5 studies | 41% ± 18% | |
endothelial cell | 5 studies | 19% ± 3% | |
pancreatic A cell | 4 studies | 34% ± 16% | |
glomerular endothelial cell | 4 studies | 44% ± 4% | |
monocyte | 4 studies | 28% ± 10% | |
adventitial cell | 4 studies | 53% ± 19% | |
mucus secreting cell | 4 studies | 36% ± 7% | |
glial cell | 4 studies | 29% ± 8% | |
duct epithelial cell | 3 studies | 45% ± 13% | |
type B pancreatic cell | 3 studies | 31% ± 10% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
podocyte | 3 studies | 29% ± 9% | |
intestinal crypt stem cell | 3 studies | 41% ± 4% | |
kidney loop of Henle epithelial cell | 3 studies | 41% ± 11% | |
renal alpha-intercalated cell | 3 studies | 33% ± 5% | |
extravillous trophoblast | 3 studies | 60% ± 21% | |
retina horizontal cell | 3 studies | 27% ± 13% | |
serous secreting cell | 3 studies | 42% ± 2% | |
myeloid cell | 3 studies | 33% ± 7% | |
Mueller cell | 3 studies | 19% ± 1% | |
conventional dendritic cell | 3 studies | 19% ± 3% | |
pancreatic ductal cell | 3 studies | 54% ± 13% | |
progenitor cell of mammary luminal epithelium | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 31% ± 11% | |
intestine | 10 studies | 28% ± 17% | |
uterus | 5 studies | 36% ± 16% | |
breast | 4 studies | 20% ± 4% | |
pancreas | 3 studies | 34% ± 11% | |
kidney | 3 studies | 23% ± 4% | |
ovary | 3 studies | 23% ± 4% | |
esophagus | 3 studies | 32% ± 21% | |
prostate | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 21791.86 | 180 / 180 | 100% | 1127.08 | 429 / 430 |
intestine | 100% | 19325.98 | 966 / 966 | 99% | 827.36 | 523 / 527 |
esophagus | 100% | 11732.42 | 1443 / 1445 | 98% | 841.33 | 180 / 183 |
thymus | 100% | 17020.62 | 652 / 653 | 98% | 660.94 | 594 / 605 |
stomach | 100% | 16769.68 | 359 / 359 | 98% | 808.39 | 279 / 286 |
lung | 100% | 19557.39 | 577 / 578 | 97% | 915.84 | 1122 / 1155 |
adrenal gland | 100% | 31200.87 | 258 / 258 | 96% | 808.25 | 221 / 230 |
uterus | 100% | 17876.59 | 170 / 170 | 96% | 729.87 | 441 / 459 |
breast | 100% | 16277.54 | 459 / 459 | 95% | 694.54 | 1060 / 1118 |
bladder | 100% | 13869.57 | 21 / 21 | 94% | 826.04 | 474 / 504 |
kidney | 99% | 15417.60 | 88 / 89 | 93% | 557.05 | 842 / 901 |
skin | 81% | 5844.75 | 1470 / 1809 | 98% | 1532.49 | 462 / 472 |
prostate | 100% | 16168.82 | 245 / 245 | 71% | 261.38 | 356 / 502 |
pancreas | 70% | 3508.02 | 231 / 328 | 98% | 780.09 | 175 / 178 |
liver | 86% | 5546.15 | 194 / 226 | 67% | 395.98 | 271 / 406 |
brain | 63% | 4093.73 | 1669 / 2642 | 77% | 274.40 | 545 / 705 |
adipose | 100% | 17424.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 1617.90 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 396.98 | 1 / 1 |
spleen | 100% | 7873.86 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 25048.76 | 855 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 12081.66 | 1297 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 541.65 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 141.92 | 17 / 29 |
muscle | 11% | 379.91 | 85 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 430.80 | 80 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007155 | Biological process | cell adhesion |
GO_0006968 | Biological process | cellular defense response |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0031089 | Cellular component | platelet dense granule lumen |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0005044 | Molecular function | scavenger receptor activity |
Gene name | LGALS3BP |
Protein name | Galectin 3 binding protein Galectin 3 binding protein (Lectin galactoside-binding soluble 3 binding protein isoform 2) Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein) Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K) |
Synonyms | hCG_1776358 M2BP |
Description | FUNCTION: Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. . FUNCTION: Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. . FUNCTION: Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. . |
Accessions | ENST00000589906.5 K7ERZ6 K7EJD3 ENST00000586720.5 ENST00000588899.1 ENST00000587311.5 ENST00000589775.6 ENST00000591778.5 K7EKQ5 K7ER67 ENST00000262776.8 ENST00000588205.5 ENST00000587310.5 ENST00000589527.5 K7ESM3 A0A0S2Z3Y1 K7ELA1 ENST00000585407.5 ENST00000591274.1 ENST00000588990.5 Q08380 ENST00000588198.5 K7EP36 K7EM15 K7EQT9 K7EN99 K7ES75 K7EJY8 ENST00000587251.5 |